According to the CDC, ZMapp has not been tested for safety or effectiveness in humans. However, one of the survivors of Ebola, Dr. Kent Brantly, was treated with ZMapp, the�Washington Post�reported. "Although ZMapp has been provided on a compassionate basis for several people in this current outbreak, we don't have enough numbers to know if the drug is effective in humans from a statistical point of view," Lai said.